Amylin Pharmaceuticals, Inc. Announces Exercise of Initial Purchasers' Option for Additional $75 Million of Convertible Senior Notes

Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) announced that the initial purchasers in its recent private placement of $500 million of 3.00% convertible senior notes due 2014 have elected to exercise their option to purchase an additional $75 million in principal amount of the notes. The offering is being made pursuant to an exemption from registration under the Securities Act of 1933, as amended. The exercise of the option will bring the gross proceeds of the private placement to $575 million upon closing. Amylin estimates that the net proceeds from this offering will be approximately $558.9 million after deducting initial purchasers' discounts and estimated expenses. The closing for the...

Want to see the full article?

• Purchase this article for only $3.00